| Source HCPCS Code |
|
Target NDC Code |
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00006-0041-68
DECADRON 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
3/30/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00006-0063-12
DECADRON (5-12 PAK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
11/22/2004 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00006-0063-68
DECADRON 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00006-0097-50
DECADRON 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/17/2003 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-3176-44
DEXAMETHASONE INTENSOL 1 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-4179-25
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-4180-25
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-4181-25
DEXAMETHASONE 1 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-4182-25
DEXAMETHASONE 1.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-4183-25
DEXAMETHASONE 2 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-4184-25
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-8174-25
DEXAMETHASONE (10X10) 1 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-8175-25
DEXAMETHASONE (10X10) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-8176-25
DEXAMETHASONE (10X10) 2 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-8179-25
DEXAMETHASONE (10X10) 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-8180-25
DEXAMETHASONE (10X10) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00054-8181-25
DEXAMETHASONE (10X10) 1.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00093-2203-01
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00093-2203-05
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00093-2203-10
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00093-2204-01
METOCLOPRAMIDE 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00093-2204-05
METOCLOPRAMIDE 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00095-0086-51
DEXPAK (TAPERPAK) 1.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
51 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00121-0576-16
METOCLOPRAMIDE 5 MG/5 ML SOLN
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
04/24/2025 |
| Number Of Items In Ndc Package |
473 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00121-1576-10
METOCLOPRAMIDE 10 MG/10 ML SOL
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00187-0247-01
CESAMET 1 MG
|
| Detail Information |
| Relationship Start Date |
7/10/2006 |
| Relationship End Date |
12/31/2006 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-0790-01
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-0791-01
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-0791-02
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-0792-01
DEXAMETHASONE 1.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-6496-01
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-6496-02
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
240 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00472-0972-08
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
9/18/2003 |
| Number Of Items In Ndc Package |
240 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00472-0972-33
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
2/24/2003 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00527-2961-37
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
03/03/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00527-2962-37
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
03/03/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00603-1145-56
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/10/2003 |
| Number Of Items In Ndc Package |
240 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00677-0601-42
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
4/10/2003 |
| Number Of Items In Ndc Package |
240 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00832-6017-00
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00832-6018-00
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00832-6018-10
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-0972-09
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
3/3/2003 |
| Number Of Items In Ndc Package |
240 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00904-2051-59
DRIMINATE 50 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00904-6516-61
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/01/2016 |
| Relationship End Date |
05/31/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00904-6517-61
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
12/15/2015 |
| Relationship End Date |
06/30/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00904-6551-61
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/05/2016 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
00904-6552-61
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/05/2016 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00904-7129-61
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/20/2021 |
| Relationship End Date |
12/31/2025 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00904-7130-06
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/14/2021 |
| Relationship End Date |
02/28/2026 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00904-7130-61
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/14/2021 |
| Relationship End Date |
02/28/2026 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00904-7375-61
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
11/06/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
00904-7376-61
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
11/06/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16571-0660-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16571-0660-50
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16571-0661-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16571-0661-10
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16714-0047-01
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/13/2020 |
| Relationship End Date |
11/30/2026 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16714-0048-01
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/13/2020 |
| Relationship End Date |
02/28/2026 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16714-0159-01
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
16714-0160-01
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
23155-0803-01
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
11/04/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
42747-0726-01
SANCUSO 3.1 MG/24 HR PATCH
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
02/28/2025 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOX |
| Route Of Administration |
TD |
| Billing Units |
TDP |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
42806-0012-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/30/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
42806-0012-10
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/30/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
42806-0014-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/30/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
42806-0014-10
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/30/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
49884-0689-01
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
11/09/2012 |
| Relationship End Date |
10/31/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
49884-0689-05
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
11/09/2012 |
| Relationship End Date |
10/31/2024 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
49999-0059-06
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
8/5/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
50268-0162-11
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/01/2020 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
50268-0163-11
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/01/2020 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
50268-0522-11
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/25/2017 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
50268-0522-15
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/25/2017 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
50268-0523-11
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/25/2017 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
50268-0523-15
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/25/2017 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
51079-0886-01
METOCLOPRAMIDE 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
06/16/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
51079-0886-20
METOCLOPRAMIDE 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
06/16/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
51079-0888-01
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/05/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
51079-0888-20
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/05/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
52536-0129-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/11/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
52536-0133-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/16/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0547-10
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0547-11
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
11 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0547-12
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0547-16
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
16 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0547-20
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0547-30
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0547-50
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
53746-0441-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
53746-0441-10
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
53746-0442-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
53746-0442-10
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0322-00
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0322-03
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0322-05
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
3/10/2005 |
| Number Of Items In Ndc Package |
7 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0324-02
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
12/27/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0324-04
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0324-06
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
6/10/2003 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0324-07
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
6/10/2003 |
| Number Of Items In Ndc Package |
8 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0324-09
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
6/26/2002 |
| Relationship End Date |
6/10/2003 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0336-01
DEXAMETHASONE 2 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-0336-03
DEXAMETHASONE 2 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
6/1/2002 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-1034-00
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
11/20/2002 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-3110-00
DEXAMETHASONE (DOSE PACK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
9/13/2004 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-5729-00
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
8/2/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
28 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0218-00
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
6/30/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0218-01
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0218-03
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
7/7/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0218-04
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
7/22/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0218-05
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
8/15/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
16 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0218-06
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
8/15/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0218-07
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
12/16/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
40 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0916-00
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-1744-00
DEXAMETHASONE 1.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3157-00
DEXAMETHASONE 2 MG
|
| Detail Information |
| Relationship Start Date |
6/21/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5334-00
DEXPAK 1.5 MG
|
| Detail Information |
| Relationship Start Date |
6/13/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
51 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1308-01
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1308-02
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1308-03
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1308-06
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
3/1/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1308-07
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1308-08
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1308-09
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
36 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1970-05
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
8 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2665-02
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2003 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55887-0377-30
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
4/1/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
57237-0075-50
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/12/2016 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
57237-0076-50
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/14/2016 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-00
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-02
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
9/15/2003 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-03
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
9/15/2003 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
150 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-12
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-15
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-20
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-30
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-73
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
9/15/2003 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
300 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0290-89
DEXAMETHASONE 0.5 MG
|
| Detail Information |
| Relationship Start Date |
9/15/2003 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
200 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0293-00
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0293-12
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0293-15
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0293-20
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0293-30
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0350-20
DEXAMETHASONE 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-00
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-10
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-12
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-14
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
14 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-15
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-20
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-21
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
21 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-24
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
24 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-28
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
28 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-30
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-40
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
40 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0781-50
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58468-0218-02
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
6/30/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
59746-0121-06
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
05/31/2026 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
59746-0121-10
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
05/31/2026 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
59746-0122-06
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
10/31/2026 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
59746-0122-10
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
10/31/2026 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
60346-0550-15
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
6/18/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
60346-0550-30
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
6/18/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
60432-0466-08
DEXAMETHASONE (RASPBERRY) 0.5 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
240 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0419-01
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
06/13/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0419-11
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
06/13/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0620-01
METOCLOPRAMIDE 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
11/15/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0620-11
METOCLOPRAMIDE 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
11/15/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0631-01
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/25/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0631-11
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/25/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0636-01
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/01/2022 |
| Relationship End Date |
04/04/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0636-11
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/01/2022 |
| Relationship End Date |
04/04/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0647-01
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
10/12/2022 |
| Relationship End Date |
04/04/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0647-11
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
10/12/2022 |
| Relationship End Date |
04/04/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0730-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/24/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0730-11
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/24/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0775-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/12/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0775-11
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/12/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
60687-0775-65
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/12/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62135-0350-05
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/06/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62135-0350-30
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/06/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62135-0351-05
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/06/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62135-0351-30
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/06/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62135-0420-90
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
12/05/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62135-0421-90
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
12/05/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62135-0526-47
METOCLOPRAMIDE 5 MG/5 ML SOLN
|
| Detail Information |
| Relationship Start Date |
04/27/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
473 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
62559-0165-01
REGLAN 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/05/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
62559-0166-01
REGLAN 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/05/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
62559-0190-16
METOCLOPRAMIDE 5 MG/5 ML SO
|
| Detail Information |
| Relationship Start Date |
07/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
473 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62559-0295-01
METOCLOPRAMIDE 5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/05/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62559-0296-01
METOCLOPRAMIDE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
12/13/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62559-0841-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/11/2022 |
| Relationship End Date |
06/30/2025 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62559-0841-10
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/11/2022 |
| Relationship End Date |
06/30/2025 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62559-0842-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/24/2022 |
| Relationship End Date |
08/31/2025 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
62559-0842-10
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
01/24/2022 |
| Relationship End Date |
10/31/2025 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62856-0796-01
AKYNZEO (HARD GELATIN) 300 MG-0.5 MG
|
| Detail Information |
| Relationship Start Date |
10/13/2014 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0444-01
DEXAMETHASONE (DOSE PAK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
5/7/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0444-12
DEXAMETHASONE (DOSE PAK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
5/7/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0444-15
DEXAMETHASONE (DOSE PAK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
5/7/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0444-20
DEXAMETHASONE (DOSE PAK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
5/7/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0444-21
DEXAMETHASONE (DOSE PAK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
5/7/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0444-30
DEXAMETHASONE (DOSE PAK) 0.75 MG
|
| Detail Information |
| Relationship Start Date |
5/7/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
65162-0441-10
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
65162-0441-11
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
65162-0442-10
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
65162-0442-11
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
04/06/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66267-0066-12
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
4/8/2002 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66336-0479-06
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
10/22/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66336-0479-15
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/19/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66336-0550-12
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
11/20/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
66689-0031-01
METOCLOPRAMIDE 5 MG/5 ML SOLN
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
07/31/2023 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
CUP |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
66689-0031-50
METOCLOPRAMIDE 5 MG/5 ML SOLN
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
07/31/2023 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
CUP |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
68084-0490-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
08/01/2011 |
| Relationship End Date |
05/31/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
68084-0490-11
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
08/01/2011 |
| Relationship End Date |
05/31/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
68084-0491-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
08/01/2011 |
| Relationship End Date |
04/21/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
68084-0491-11
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
08/01/2011 |
| Relationship End Date |
04/21/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0096-12
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
4/19/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0096-14
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
4/19/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
14 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0096-30
DEXAMETHASONE 0.75 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0097-04
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0097-15
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0097-20
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
10/26/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0097-30
DEXAMETHASONE 4 MG
|
| Detail Information |
| Relationship Start Date |
6/8/2004 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0435-10
DEXAMETHASONE 1.5 MG
|
| Detail Information |
| Relationship Start Date |
6/28/2005 |
| Relationship End Date |
12/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
68462-0861-01
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
03/24/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
68462-0862-01
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
03/24/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
69238-1054-01
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/24/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESECRIPTION ANTIEMETIC
|
⇄
|
69238-1056-01
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
09/24/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
69339-0171-03
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/11/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
69339-0171-05
ONDANSETRON HCL 4 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/11/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
69339-0172-03
ONDANSETRON HCL 8 MG TABLET
|
| Detail Information |
| Relationship Start Date |
07/11/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
UNSPECIFIED ORAL DOSAGE FORM, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR A IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
69656-0101-02
VARUBI (FILM COATED) 90 MG
|
| Detail Information |
| Relationship Start Date |
9/7/2015 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
70199-0018-01
ANTIVERT 25 MG CHEWABLE TABLET
|
| Detail Information |
| Relationship Start Date |
03/03/2017 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
70710-1161-00
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/04/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
70710-1161-01
MECLIZINE 12.5 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/04/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
70710-1162-00
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/04/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
70710-1162-01
MECLIZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
02/04/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
72205-0104-91
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
05/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
90096-0131-01
CHLORPROMAZINE 10 MG TABLET
|
| Detail Information |
| Relationship Start Date |
06/02/2022 |
| Relationship End Date |
12/01/2023 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|
Q0181
Unspecified oral, FDA approved RX anti-emetic, for use as a complete therapeutic substitute for a IV
|
⇄
|
90096-0132-01
CHLORPROMAZINE 25 MG TABLET
|
| Detail Information |
| Relationship Start Date |
06/01/2022 |
| Relationship End Date |
03/01/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
TAB |
|
|
|